FDA Investigator Wanda Y Honeyblue

Wanda Y Honeyblue has inspections in 1 countries as of 26 Oct 2023. Wanda Y Honeyblue has collaborated with a combinined 2950 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
92
Last Inspection Date:
26 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
100007118
Country:
United States of America
Co-Investigator(s):
Alice S Tsao, Alicia M Mozzachio, Alison N Stieg, Amanda B Athey, Amanda B Vega, Ana P Barido, Anthony W Lee, Armando P Zamora, Ashley M Whitehurst, Barbara A Burke, Barbara A Gullick, Barbara J Holladay, Bijoy Panicher, Bijoy Panicker, Braedyn K Kromer, Brandon L Mariner, Brian S Lynch, Brooke K Higgins, Brooke K Seeman, Camilla S Smith, Chaltu N Wakijra, Charles D Boison, Charles E Idjagboro, Charles M Kerns, BLT DO, Cherlita A Honeycutt, Chiang Syin, PhD, Christina K Theodorou, Christine W Twohy, Chryste D Best, Clarice J Ahn, David A Oluwo, David L Chon, Denise R Beuttenmuller, Diane T Bargo, Diane T O'brien, Donald L Lech, Douglas A Campbell, Dr. Dominick Roselle, Dr. Roslyn F Powers, Dr. Yubing Tang, Edmund F Mrak, Jr, Edward P Potter, Elvis D Morton, Emest F Bizjak, Emmanuel A Dimaano, Jr, Erik T Nagaoka, Erik W Koester, Erika M Wilkerson, Erin L Mcfiren, Erk W Koester, Esaw, Gail L Katz, Gale L Glinecki, George Pyramides, Gerald B Seaborn, Jr, Gerald Mierle, Heath R Harley, Hector J Colon Torres, Holly S Simms, Ingrid Y Johnson, James M Mason, James M Simpson, James T Mccoy, James W Leonette, Jamie D Swann, Jean Blackston Hill, Jeanne D Shaffer, Jesse P Hardin, Joanne S Wilson, John Dan, John M Gusto, Johnson, Jonah S Ufferfilge, Jonah Ufferfilge, Jonathan W Chapman, Jose R Hernandez, Joseph W Matthews, Junho Pak, Justin H Price, Karen M Bryerton, Karen M Cooper, Kathleen M Jordan, Kathryn Suttling, Kenneth Gordon, Kenneth M Gordon, Kenneth Nieves, Ko U Min, Krista N Flores, Kristina L Conroy, La Tasha M Gunter, Latoya S Oliver Powell, Laurie P Norwood, Laurissa S Flowers, Lawrence Harmon, Jr, LCDR Anastasia Mpiliafas Brown, Linda S Mattingly, Lori A Holmquist, Lori A Holquist, Lori S Lawless, LT John M Mastalski, LT Melanie M Mayor, USPHS, Lynette P Salisbury, Marcellinus D Dordunoo, Marcus A Ray, Margaret M Doherty, Margaret Torres Vazquez, Marilyn M White, Marion W Nadeau, Mary T Carden, Matthew M Henciak, Melissa J Garcia, Merideth K Rose, Michael D Ellison, Michael Shanks, MS, Michele M Falchek, Mildred L Mccray, Monique Rac Lester, Mpris Inspector, Nancy L Meade, Nancy L Rose, Natasha A Dezinna, Nebil A Oumer, Nerizza B Guerin, Nicholas A Violand, Nina D Patel, Normica G Facey, Patricia A Morrow, Patrick C Klotzbuecher, Paula J Bretz, Rachael O Oyewole, Rachael Oyewole, Rachel C Harrington, Rebecca Rodriguez, Regina Gibson Melton, Richard J Bashay, Robert J Martin, Sharon K Thoma, PharmD, Shavon L Square, Shirshendu K Deb, PhD, Shusheen A Alexander, Simone E Pitts, Stacey A Priest, State Agency, Stephanie L Shapley, Stephanie Mangigian, MS/OSH, RN, Stephen R King, Suzanne M Healy, Suzanne M Muchene, Tamara N Champion, Tamika E Allen, RN, Teresa L Fox, Theresa M Smedley, Tiffani D Wilson, Tonia F Bernard, Toyin B Oladimeji, Valerie G Vallely, Vesna V Stanoyevitch, Viviana Matta, Vivin George, Walter L Fava, Wanda Y Fields, Wayne L Jefferson, Yvins Dezan, Yvonne C Mcknight, Zhongren Wu

Wanda Y Honeyblue's Documents

Publish Date Document Type Title
July, 2003 EIR NIH Clinical Center - EIR, 2003-07-02
October, 2003 EIR Johns Hopkins Bayview Medical Center Blood Bank - EIR, 2003-10-31
May, 2003 EIR Baltimore Washington Medical Center - EIR, 2003-05-29
November, 2003 EIR Hildenbrand International, Inc. DBA Osteo Concepts - EIR, 2003-11-17
February, 2003 FDA 483 Response Johns Hopkins Hospital Blood Bank - Form 483R, 2003-04-16
September, 2002 EIR Transplant Resource Center of Maryland - Tissue Ste. - EIR, 2002-09-12
July, 2002 EIR University of Maryland Medical Center Midtown Campus - EIR, 2002-07-22
May, 2003 FDA 483 Response St Agnes Healthcare Blood Bank - Form 483R, 2003-07-02
January, 2002 EIR Adventist Healthcare - EIR, 2002-01-28
July, 2002 FDA 483 Response University of Maryland Medical Center Midtown Campus - Form 483R, 2002-08-05
July, 2003 EIR Adventist Healthcare - EIR, 2003-07-24
November, 2002 EIR Pharmaceutics International, Inc. - EIR, 2002-11-14
May, 2003 EIR St Agnes Healthcare Blood Bank - EIR, 2003-05-21
March, 2002 EIR The Johns Hopkins Hospital HATS Service - EIR, 2002-03-07
April, 2003 EIR Culligan Water Company of Maryland, Inc. - EIR, 2003-04-02
March, 2003 EIR Sinai Hospital Of Baltimore Blood Bank - EIR, 2003-03-10
January, 2002 FDA 483 Adventist Healthcare - Form 483, 2002-01-28
February, 2002 EIR Union Memorial Hospital Bb - EIR, 2002-02-20
August, 2002 FDA 483 Response NIH Clinical Center - Form 483R, 2002-08-30
March, 2002 EIR Washington Adventist Hospital - EIR, 2002-03-26
April, 2003 FDA 483 Response Mercy Medical Center - Form 483R, 2003-06-14
April, 2002 EIR St Joseph's Medical Center - EIR, 2002-04-02
September, 2001 EIR Actavis Mid-Atlantic, LLC. - EIR, 2001-09-27
April, 2002 EIR Carroll Hospital Center, Inc. - EIR, 2002-04-25
January, 2003 EIR BRT Laboratories, Inc. - EIR, 2003-01-27
November, 2002 FDA 483 Pharmaceutics International, Inc. - Form 483, 2002-11-14
August, 2003 EIR CorneaGen - EIR, 2003-08-27
November, 2002 FDA 483 Response Pharmaceutics International, Inc. - Form 483R, 2002-11-14
February, 2004 EIR Transplant Resource Center of Maryland - Tissue Ste. - EIR, 2004-02-19
August, 2002 EIR NIH Clinical Center - EIR, 2002-08-07
January, 2003 EIR Good Samaritan Hosp Of Md Inc - EIR, 2003-01-08
December, 2003 EIR Mid Atlantic Medical - EIR, 2003-12-04
February, 2003 EIR Johns Hopkins Hospital Blood Bank - EIR, 2003-02-25
February, 2002 EIR Grifols Bio Supplies Inc. - EIR, 2002-02-11
May, 2002 EIR UMD Medical System Blood Bank - EIR, 2002-05-14
May, 2002 FDA 483 Response UMD Medical System Blood Bank - Form 483R, 2002-05-29
April, 2003 EIR Mercy Medical Center - EIR, 2003-04-28
February, 2004 EIR Transplant Resource Center of Maryland - EIR, 2004-02-19
May, 2002 EIR Marlene And Stewart Greenbaum Cancer Center - EIR, 2002-05-29
December, 2003 EIR Rock Surgical Associates, Inc. - EIR, 2003-12-01
June, 2003 FDA 483 Response Howard University Hospital BB - Form 483R, 2003-07-02
September, 2002 FDA 483 Transplant Resource Center of Maryland - Form 483, 2002-09-12
September, 2001 FDA 483 Response Actavis Mid-Atlantic, LLC. - Form 483R, 2002-03-07
June, 2003 EIR Howard University Hospital BB - EIR, 2003-06-19
September, 2002 EIR Transplant Resource Center of Maryland - EIR, 2002-09-12
May, 2003 FDA 483 St Agnes Healthcare Blood Bank - Form 483, 2003-05-21
August, 2003 EIR Department of Veterans Affairs Med Center - EIR, 2003-08-07
August, 2002 EIR Osiris Therapeutics Inc - EIR, 2002-08-22
January, 2004 EIR Gift of Hope Donor Services of Maryland, Inc. - EIR, 2004-01-06
April, 2003 FDA 483 Mercy Medical Center - Form 483, 2003-04-28
January, 2002 EIR Greater Baltimore Medical Center - EIR, 2002-01-07
September, 2002 FDA 483 Response Transplant Resource Center of Maryland - Form 483R, 2002-09-24
June, 2000 FDA 483 Shire Pharmaceuticals, Inc. - Form 483, 2000-06-23
August, 2002 FDA 483 NIH Clinical Center - Form 483, 2002-08-07
July, 2002 FDA 483 University of Maryland Medical Center Midtown Campus - Form 483, 2002-07-22
February, 2003 FDA 483 Johns Hopkins University, The - Form 483, 2003-02-25
July, 2003 EIR Greater Baltimore Medical Center - EIR, 2003-07-21
June, 2003 FDA 483 Howard University Hospital Blood Bank - Form 483, 2003-06-19
May, 2002 FDA 483 UMD Medical System Blood Bank - Form 483, 2002-05-14
January, 2003 EIR Harbor Hospital Blood Bank - EIR, 2003-01-17
September, 2001 FDA 483 Actavis Mid-Atlantic, LLC. - Form 483, 2001-09-27
June, 2000 EIR Shire Pharmaceuticals, Inc. - EIR, 2000-06-23
July, 2002 EIR Anne Arundel Medical Center Blood Bank - EIR, 2002-07-03

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more